FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and can be used for long-term treatment of depression or anxiety for longer than 12-month period in patient who previously received drug treatment, with treatment being stopped because of undesirable side effects, associated with body weight. For this purpose 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine and/or its pharmaceutically acceptable salts are applied. Also claimed are: method of long-term treatment of depression or anxiety and application of 1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine and/or its pharmaceutically acceptable salts for production of medication.
EFFECT: group of inventions provides reduction of side effects, associated with change of patient's body weight in long-term treatment.
15 cl, 4 tbl, 2 ex
| Title |
Year |
Author |
Number |
| COMBINATION OF PI3 KINASE INHIBITOR WITH PACLITAXEL FOR USE IN TREATMENT OR PREVENTION OF HEAD AND NECK CANCER |
2014 |
- Khiravat Samit
- Massachezi Kristian
- Di Tomazo Emmanyuell
|
RU2672555C2 |
| METHOD OF PRODUCING 1-[2-(2,4-DIMETHYL-PHENYLSULPHANYL)PHENYL]PIPERAZINE |
2012 |
|
RU2608307C2 |
| TREATMENT OF INTRAHEPATIC CHOLESTATIC DISEASES |
2017 |
- Baudes Pol
- Makuerter Charlz A.
|
RU2765460C2 |
| BETA-LACTAM COMPOUNDS OR SALTS THEREOF FOR USE IN LONG-TERM PREVENTION OR TREATMENT OF IMPAIRED GLUCOSE METABOLISM |
2020 |
- Lee, Feng Lin
- Lin, Lung Jr.
- Hsu, Jyh Shing
- Hsu, Cheng Hsien
- Huang, Yen Chun
- Huang, Ya Chien
- Lo, Chun Tsung
- Liao, Hui Fang
- Liu, Yu Wen
- Kao, Yu Chi
|
RU2830748C2 |
| INTRANASAL ADMINISTRATION OF ESKETAMINE |
2020 |
- Dzhimidar M. Ilias
- Van Tszinli
- Arts Karolina
- Verbryuggen Katrin
- Tenis Sarte
- Singkh Dzhaskaran
- Kajens Kris
- Zannikos Piter
- Yan Khun
|
RU2830614C1 |
| USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS |
2014 |
- Zhang Xiaoming
- Schnipper Edward F.
- Perlman Andrew J.
- Larrick James W.
|
RU2666219C2 |
| COMBINATION OF MEDICINAL AGENTS COMPRISING MIRTAZAPINE FOR TREATMENT OF DEPRESSION AND ASSOCIATED DISORDERS |
2001 |
- Ehndrjus Dzhon Stjuart
- Drinkenburg Vil'Khel'Mus
- Vard Nikolas Meht'Ju
|
RU2268725C2 |
| KAPPA-OPIOID AGONISTS FOR TREATMENT OF DIARRHEA-PREVAILING IRRITABLE BOWEL SYNDROME AND ALTERNATE IRRITABLE BOWEL SYNDROME |
2008 |
|
RU2441655C2 |
| (4-METHOXY-7-MORPHOLIN-4-YL-BENZOTHIAZOL-2-YL)AMIDE 4-HYDROXY-4-METHYLPIPERIDINE-1-CARBOXYLIC ACID FOR TREATING POST-TRAUMATIC STRESS DISORDER |
2008 |
|
RU2500401C2 |
| MILNACIPRAN AS MEDICATION FOR CONTINUOUS TREATMENT OF FIBROMYALGIA SYNDROME |
2006 |
- Rao Srinivas G.
- Zhandro Majkl
- Kranzler Dzhej D.
|
RU2437661C2 |
